Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05272163 · ClinicalTrials.gov registry record · NA

Brief Title: Project 4 Example: Mixed Hybrid Checklist

A NA study of Incidental Findings and Visual Attention, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT05272163: Completed NA study of Incidental Findings and Visual Attention, sponsored by Brigham and Women's Hospital.

NCT05272163 is a NA study of Incidental Findings and Visual Attention that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05272163, a NA study of Incidental Findings and Visual Attention, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

In "Mixed Hybrid Search", participants look for 3 specific target (e.g. this boot, this cat, this hat) and 3 categorical items (ANY fruit, ANY car, ANY game). In this task, participants tend to miss many categorical items. This is analogous to radiologists missing "incidental findings" when reading medical images. In this experiment, participants were given a checklist to help them to find categorical targets.

Primary Outcome

Did the Participant get the right answer?

Interventions

  • BEHAVIORAL Checklist
  • BEHAVIORAL Stimulus Type
  • BEHAVIORAL Target Presence

Study Locations (1)

Massachusetts

  • Visual Attention Lab / Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2018-01-17
Est. Completion 2024-01-01
Phase NA
Brigham and Women's Hospital

937 total trials

What the finished NCT05272163 record still lists

NCT05272163 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 4 conditions, with Incidental Findings appearing as the primary indexed condition, and to 3 interventions - of which Checklist is the first listed.

NCT05272163 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05272163 about?

NCT05272163 is a clinical study titled "Brief Title: Project 4 Example: Mixed Hybrid Checklist". In "Mixed Hybrid Search", participants look for 3 specific target (e.g. this boot, this cat, this hat) and 3 categorical items (ANY fruit, ANY car, ANY game). In this task, participants tend to miss many categorical items. This is analogous to radiologists missing "incidental findings" when reading ...

What is the current status of trial NCT05272163?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2018-01-17. Estimated completion is 2024-01-01.

What conditions does trial NCT05272163 study?

This clinical trial studies the following conditions: Incidental Findings, Visual Attention, Visual Search, Hybrid Search.

What interventions are being tested in trial NCT05272163?

The interventions under investigation include: Checklist (BEHAVIORAL), Stimulus Type (BEHAVIORAL), Target Presence (BEHAVIORAL).

Who is sponsoring clinical trial NCT05272163?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05272163 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT05272163's enrollment target sits among peer trials

12 1913th of 2000 higher than 74 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05272163, the US trial registry maintained by the National Library of Medicine. NCT05272163 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.